Phase 2 Readout
EPRX: Phase 2 Readout: ep-104gi
December 31, 2026 · ep-104gi. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- EUPRAXIA PHARMACEUTICALS INC. (EPRX)
- Drug
- ep-104gi
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: ep-104gi
- Drug
- ep-104gi
- Indication
- Eosinophilic Esophagitis